Dong-yi Y. Chen

Linkou Branch
Taoyuan, TNQ, Taiwan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 100 publications

Effectiveness and Safety of Bempedoic Acid in Taiwanese Patients With Hypercholesterolemia: A Pragmatic Phase 4 Study (CLEAR Taiwan Study).

Effectiveness and Safety of Bempedoic Acid in Taiwanese Patients With Hypercholesterolemia: A Pragmatic Phase 4 Study (CLEAR Taiwan Study).

Journal: Journal of the American Heart Association

Published: May 14, 2026

Prognostic value of peak tricuspid regurgitation velocity in hospitalized patients with heart failure with preserved ejection fraction: an multi-institutional study.

Prognostic value of peak tricuspid regurgitation velocity in hospitalized patients with heart failure with preserved ejection fraction: an multi-institutional study.

Journal: Annals of medicine

Published: April 10, 2026

Glucagon-Like Peptide-1 Receptor Agonists and Prior Major Adverse Limb Events in Patients With Diabetes.

Glucagon-Like Peptide-1 Receptor Agonists and Prior Major Adverse Limb Events in Patients With Diabetes.

Journal: JAMA network open

Published: January 28, 2026

Human iPSC-EV-loaded nanofiber stent coatings accelerate vascular repair by enhancing EGFR/HIF-1α signaling and suppressing ROCK1-mediated remodeling.

Human iPSC-EV-loaded nanofiber stent coatings accelerate vascular repair by enhancing EGFR/HIF-1α signaling and suppressing ROCK1-mediated remodeling.

Journal: Materials today. Bio

Published: January 01, 2026

Lipoprotein(a) and Mortality in Primary Prevention: Only Very High Levels Matter - Authors' reply.

Lipoprotein(a) and Mortality in Primary Prevention: Only Very High Levels Matter - Authors' reply.

Journal: European journal of preventive cardiology

Published: November 09, 2025

GLP-1 RAs and Cardiovascular and Kidney Outcomes by Body Mass Index in Type 2 Diabetes.

GLP-1 RAs and Cardiovascular and Kidney Outcomes by Body Mass Index in Type 2 Diabetes.

Journal: JAMA network open

Published: September 08, 2025

Outcomes of End Stage Renal Disease in Patients With Infective Endocarditis: A Nationwide Population-Based Study.

Outcomes of End Stage Renal Disease in Patients With Infective Endocarditis: A Nationwide Population-Based Study.

Journal: Journal of the American Heart Association

Published: August 23, 2025

Comparative effectiveness and safety of enzalutamide versus abiraterone in patients with metastatic castration-resistant prostate cancer: a nationwide registry-based cohort study from Taiwan.

Comparative effectiveness and safety of enzalutamide versus abiraterone in patients with metastatic castration-resistant prostate cancer: a nationwide registry-based cohort study from Taiwan.

Journal: Journal of cancer research and clinical oncology

Published: August 07, 2025

Predicting Cardiovascular Risk in Patients with Prostate Cancer Receiving Abiraterone or Enzalutamide by Using Machine Learning.

Predicting Cardiovascular Risk in Patients with Prostate Cancer Receiving Abiraterone or Enzalutamide by Using Machine Learning.

Journal: Cancers

Published: May 19, 2025

Impact of ejection fraction changes on long-term outcomes in VA-ECMO patients.

Impact of ejection fraction changes on long-term outcomes in VA-ECMO patients.

Journal: Medicine

Published: May 19, 2025

Retrospective cohort analysis of low-molecular-weight heparin versus non-vitamin K antagonist oral anticoagulants for venous thromboembolism prophylaxis across racial groups in hospitalized trauma patients.

Retrospective cohort analysis of low-molecular-weight heparin versus non-vitamin K antagonist oral anticoagulants for venous thromboembolism prophylaxis across racial groups in hospitalized trauma patients.

Journal: International journal of surgery (London, England)

Published: May 13, 2025

SGLT2i with ARNi versus RASi in heart failure with reduced ejection fraction: Improved survival and reduced hyperkalemia risk in a real-world cohort study.

SGLT2i with ARNi versus RASi in heart failure with reduced ejection fraction: Improved survival and reduced hyperkalemia risk in a real-world cohort study.

Journal: Journal of cardiology

Published: April 26, 2025

Showing 1-12 of 100

Last Updated: 09/26/2026